| Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer S Gao, S Chen, D Han, Z Wang, M Li, W Han, A Besschetnova, M Liu, ... Nature genetics 52 (10), 1011-1017, 2020 | 103 | 2020 |
| ZBTB7A mediates the transcriptional repression activity of the androgen receptor in prostate cancer D Han, S Chen, W Han, S Gao, JN Owiredu, M Li, SP Balk, HH He, C Cai Cancer research 79 (20), 5260-5271, 2019 | 30 | 2019 |
| LSD1 Inhibition Disrupts Super-Enhancer–Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer M Li, M Liu, W Han, Z Wang, D Han, S Patalano, JA Macoska, SP Balk, ... Cancer Research 83 (10), 1684-1698, 2023 | 28 | 2023 |
| RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibition W Han, M Liu, D Han, M Li, AA Toure, Z Wang, A Besschetnova, ... Oncogene 41 (6), 852-864, 2022 | 28 | 2022 |
| Exploiting the tumor-suppressive activity of the androgen receptor by CDK4/6 inhibition in castration-resistant prostate cancer W Han, M Liu, D Han, AA Toure, M Li, A Besschetnova, Z Wang, ... Molecular Therapy 30 (4), 1628-1644, 2022 | 25 | 2022 |
| LSD1 activates PI3K/AKT signaling through regulating p85 expression in prostate cancer cells Z Wang, S Gao, D Han, W Han, M Li, C Cai Frontiers in oncology 9, 721, 2019 | 17 | 2019 |
| Increased AR expression in castration-resistant prostate cancer rapidly induces AR signaling reprogramming with the collaboration of EZH2 M Labaf, M Li, L Ting, B Karno, S Zhang, S Gao, S Patalano, JA Macoska, ... Frontiers in Oncology 12, 1021845, 2022 | 12 | 2022 |
| SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1 Z Wang, J Petricca, M Liu, S Zhang, S Chen, M Li, A Besschetnova, ... Proceedings of the National Academy of Sciences 120 (33), e2220472120, 2023 | 11 | 2023 |
| Androgen receptor splice variants drive castration-resistant prostate cancer metastasis by activating distinct transcriptional programs D Han, M Labaf, Y Zhao, J Owiredu, S Zhang, K Patel, K Venkataramani, ... The Journal of Clinical Investigation, 2024 | 6 | 2024 |
| FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer Z Wang, SL Townley, S Zhang, M Liu, M Li, M Labaf, S Patalano, ... Nature Communications 15 (1), 4914, 2024 | 5 | 2024 |
| Susceptibility-Associated Genetic Variation in NEDD9 Contributes to Prostate Cancer Initiation and Progression D Han, JN Owiredu, BM Healy, M Li, M Labaf, JS Steinfeld, S Patalano, ... Cancer research 81 (14), 3766-3776, 2021 | 5 | 2021 |
| Demethylation of EHMT1/GLP protein reprograms its transcriptional activity and promotes prostate cancer progression A Besschetnova, W Han, M Liu, Y Gao, M Li, Z Wang, M Labaf, S Patalano, ... Cancer Research Communications 3 (8), 1716-1730, 2023 | 2 | 2023 |
| Targeting prostate cancer super enhancers by co-inhibiting LSD1 and BRD4 S Gao, M Li, M Liu, D Han, Z Wang, W Han, C Cai Cancer Research 81 (13_Supplement), 2317-2317, 2021 | 1 | 2021 |
| Effects of Exercise Training on Prostate Cancer: Current Evidence and Potential Molecular Mechanisms M Webber, M Li, C Cai, K Zou Advanced Exercise and Health Science, 2024 | | 2024 |
| Voluntary Exercise Attenuates Tumor Growth in a Preclinical Model of Castration-Resistant Prostate Cancer N Berger, B Kugler, D Han, M Li, P Nguyen, M Anderson, S Zhang, C Cai, ... bioRxiv, 2024.10. 16.617081, 2024 | | 2024 |
| Voluntary Wheel Running Alters Mitochondrial Fission Protein Drp1 In A Mouse Model Of Prostate Cancer: 1884 NJ Berger, BA Kugler, M Li, D Han, M Anderson, P Nguyen, C Cai, K Zou Medicine & Science in Sports & Exercise 55 (9S), 644, 2023 | | 2023 |
| Abstract A009: Distinct activity of androgen receptor splice variants in promoting prostate cancer metastasis M Labaf, D Han, Y Zhao, J Owiredu, S Zhang, K Venkataramani, ... Cancer Research 83 (11_Supplement), A009-A009, 2023 | | 2023 |
| LSD1 &8211mediated FOXA2/AP1 transcription program drives lineage plasticity in prostate cancer Z Wang, M Liu, S Zhang, M Li, S Patalano, JA Macoska, D Han, S Gao, ... Cancer Research 83 (7_Supplement), 4753-4753, 2023 | | 2023 |
| LSD1 activates oncogenic super-enhancers in castration-resistant prostate cancer by forming nuclear condensates with BRD4 M Liu, M Li, D Han, Z Wang, W Han, HH He, S Gao, C Cai Cancer Research 83 (7_Supplement), 4729-4729, 2023 | | 2023 |
| Targeting Novel Oncogenic Activities of LSD1 in Prostate Cancer M Li University of Massachusetts Boston, 2023 | | 2023 |
